Logo American Journal of Case Reports

Call: 1.631.629.4328
Mon-Fri 10 am - 2 pm EST

Contact Us

Logo American Journal of Case Reports Logo American Journal of Case Reports Logo American Journal of Case Reports

21 July 2020: Articles  USA

A Rare Case of Non-Prosthetic Aortic Valve Infectious Endocarditis Caused by

Rare disease

Ricardo Lessa de Castro A* , Neiberg de Alcantara Lima C , Danielli Oliveira da Costa Lino B , Thomas Austin Melgar A

DOI: 10.12659/AJCR.923031

Am J Case Rep 2020; 21:e923031



BACKGROUND: Achromobacter xylosoxidans is a ubiquitous environmental gram-negative bacterium, very resistant to antibiotics. Endocarditis caused by these bacteria is extremely rare, with only 20 cases described in the literature to our knowledge. Mortality rates are high, and treatment usually involves a combination of antibiotics and surgery. Nosocomial infections predominate with a strong association between bacteremia and immunosuppression.

CASE REPORT: A 19-year-old immunocompetent male presented with endocarditis He had interatrial and interventricular communication corrected at age 11 months and aortic coarctation correction at age 10. Initial echocardiogram showed a possible interventricular patch infection, which was later ruled out. He was treated initially for endocarditis with a combination of antibiotics, but because he remained febrile after appropriate antibiotic treatment, surgery was performed. The patient had a favorable outcome after surgery and was asymptomatic on follow-up.

CONCLUSIONS: Endocarditis caused by A. xylosoxidans is extremely rare. To date, only 20 cases of IT have been reported in the literature, of which only two involved a native valve. Given the scarcity of cases reported, there is no consensus on the best treatment.

Keywords: Achromobacter denitrificans, Endocarditis, Bacterial, Heart Valves, Adult, Aortic Valve, Child, Endocarditis, Gram-Negative Bacterial Infections, Infant, Male, young adult


Achromobacter xylosoxidans is a ubiquitous, environmental gram-negative bacterium, very resistant to antibiotics. Endocarditis caused by these bacteria is extremely rare, with only 20 cases described in the literature to our knowledge. Mortality rates are high [1], and treatment usually involves a combination of antibiotics and surgery. Nosocomial infections predominate with a strong association between bacteremia and immunosuppression [2]. Here, we present a case of endocarditis caused by these uncommon bacteria in the native valve in an immunocompetent patient with no recent hospitalizations and a history of cardiac surgery, who survived after a combination of surgical and antibiotic treatment.

Case Report

A 19-year-old man presented with a history of approximately 1 month of intermittent fevers, chills, dry cough, and pleuritic chest pain. He lost about 10 lb during this period and had progressive fatigue. He had a medical history of interatrial and interventricular communication corrected at 11 months of age and aortic coarctation correction at age 10.

On examination, the patient was febrile, tachycardic, and his blood pressure was 125 over 76 mmHg. Physical exam demonstrated diastolic aortic murmur, grade 3/6, compatible with aortic insufficiency. There was no jugular vein distention, the lung exam was clear, and there were no petechiae or signs of skin lesions. The rest of the patient’s physical exam was normal. Laboratory testing revealed an elevated white blood cell count of 16.45 109/L and microcytic anemia with hemoglobin of 9.1 g/dL and mean corpuscular volume of 78 fL. Creatinine was 0.71 mg/dL with a glomerular filtration rate above 60 mL/min. An HIV test done on our patient was negative. Chest x-ray showed signs of mild pulmonary congestion and an enlarged cardiac silhouette. An echocardiogram revealed a moderate left atrium enlargement and eccentric left ventricular hyper-trophy with an ejection fraction of 47%. A filamentous structure was also seen inside the patient’s left ventricle, adherent to a bicuspid aortic valve, and the ventricular patch in his inter-ventricular septum and severe aortic insufficiency. A diagnosis of endocarditis was given and the patient was placed on gentamicin, oxacillin, and ceftriaxone.

Two sets of blood cultures collected on the patient’s admission were positive for presence of Achromobacter xylosoxidans sensitive only to carbapenem with minimum inhibitory concentrations (MIC) of 0.5 and resistant to oxacillin and ceftriaxone MIC 16 for both. The antibiotics were switched but the patient continued to have fevers after 7 days of appropriate antibiotics associated with increased shortness of breath and lung congestion compatible with acute heart failure. Subsequent blood cultures performed on Day 5 of antibiotics were still positive. Because of the patient’s clinical non-response and acute-onset heart failure associated with aortic insufficiency, a surgical procedure was scheduled [3].

During the surgery, vegetation was seen on the patient’s aortic valve but not on his ventricular patch. Culture of the vegetation showed A xylosoxidans. The surgery was done with no major complications. He went to intensive care on moderate doses of vasopressors and was extubated 12 hours after the procedure.

On the fourth day of the patient’s hospitalization, he had a spontaneous right-sided pneumothorax, with no apparent cause, which was drained and resolved after 3 days. He went home 10 days after surgery and completed 28 days of carbapenem. His immediate and 30-day echocardiograms at follow-up did not show any vegetation. He was symptomatic at his 6-month and 1-year follow-up appointments.


Endocarditis is dangerous and difficult to treat. Prolonged fevers with weight loss in patients with a previous history of heart disease, especially after cardiac surgeries, should raise suspicion of this diagnosis.

A. xylosoxidans is an aerobic, motile, gram-negative rod that was first described in 1971 by Yabuuchi and Ohyama, who discovered it in patients with chronic, purulent otitis media [4]. Infections with A. xylosoxidans have included meningitis, pneumonia, peritonitis, and urinary tract infections [5,6]. However, bacteremia associated with prosthetic or native valve endocarditis caused by A. xylosoxidans is rare.

A recent review published by Barragan, et al. showed that in the majority of cases, patients were immunocompromised and almost all had acquired their infections in the hospital [7]. Reviewing our patient’s records, he had no history of recent or recurrent illnesses or hospitalizations. In most patients, infections associated with this pathogen are related to catheters [7,8] but in our report, we do not have a clear source of his infection.

To date, only 20 cases (Table 1) of A. xylosoxidans endocarditis have been reported in the literature, of which only two involved a native valve [8–28]. Considering the treatment and outcome: 11 of 19 (58%) required surgical intervention; 8 of 17 (47%) died, 2 of the 8 deaths (22%) were from the operated group and the other 6 (75%) were from the clinically treated group [10].

Given the scarcity of the cases reported, there is no consensus on the best treatment for A. xylosoxidans endocarditis. Antipseudomonal penicillin and carbapenems are the best choices, based on bacteriologic studies and case reports [11].

In contrast to use of a percutaneous atrial septal occluder device, surgical patch closure of atrial septal defects is known to represent no risk infective endocarditis [12]. To our knowledge, only two cases of endocarditis on a surgical patch of a ventricular septal defect have been reported [12]. Considering these previous case reports, it would be unlikely for our patient to have an infection in his patch. However, his bicuspid aortic valve increases his risk of developing endocarditis.


We presented an uncommon and rare case of A. xylosoxidans as the cause of infective endocarditis in a young, immunocompetent patient. The bacteria is very resistant and the treatment usually requires broad-spectrum antibiotics associated with surgical procedures. Our patient had a good outcome and was asymptomatic in later follow up.


1.. Xia R, Otto C, Zeng J: Cardiovasc Pathol, 2018; 36; 6-10

2.. Manfredi R, Nanetti A, Ferri M, Chiodo F: Eur J Clin Microbiol Infect Dis, 1997; 16(12); 933-38

3.. Baddour LM, Wilson WR, Bayer AS: Circulation, 2015; 132; 1435-86

4.. Ohyama A, Yabuuchi O: Jpn J Microbiol, 1971; 15(70028); 477-81

5.. Shigeta S, Yasunaga Y, Honzumi K: J Clin Pathol, 1978; 31(2); 156-61

6.. Igra-Siegman Y, Chmel H, Cobbs C: J Clin Microbiol, 1980; 11(2); 141-45

7.. Barragán EP, Pérez JS, Corbella L: Rev Esp Quimioter, 2018; 31(3); 268-73

8.. Levoy CS, Hall DJ, Berman D: JMM Case Rep, 2015; 2(6); 1-4

9.. Tea I, Caruso M, Gary P: J Am Coll Cardiol, 2019; 73(9 Suppl. 1); 2999

10.. Rodrigues CG, Rays J, Kanegae MY: Autops Case Rep, 2017; 7(3); 50-55

11.. Derber C, Elam K, Forbes BA, Bearman G: Can J Infect Dis Med Microbiol, 2011; 22(3); e17-e20

12.. Honnorat E, Seng P, Riberi A: BMC Res Notes, 2016; 9(1); 16-19

13.. Kumar S, Khaira J, Penigalapati D, Apurva A: J Glob Infect Dis, 2017; 9(2); 85

14.. Rafael AE, Keshavamurthy S, Sepulveda E: Texas Hear Inst J, 2014; 41(3); 324-26

15.. Sawant AC, Srivatsa SS, Castro LJ: Texas Hear Inst J, 2013; 40(1); 95-98

16.. Tokuyasu H, Fukushima T, Nakazaki H, Shimizu E: Intern Med, 2012; 51(9); 1133-38

17.. Storey A, Wilson A, McWilliams E: BMJ Case Rep, 2010; 2010; bcr0620103104

18.. Malek-Marín T, Arenas MD, Perdiguero M: Clin Nephrol, 2009; 72(5); 405-9

19.. Ahmed MS, Nistal C, Jayan R: Clin Nephrol, 2009; 71(3); 350-54

20.. Van Hal S, Stark D, Marriott D, Harkness J: J Med Microbiol, 2008; 57(4); 525-27

21.. Yang CH, Shih NC, Lu DCT: J Intern Med Taiwan, 2007; 18(4); 212-16

22.. Nanuashvili A, Kacharava G, Jashiashvili N: Euro Surveill, 2007; 12(5); E070524.2

23.. Ahn Y, Kim NH, Shin DH: J Korean Med Sci, 2004; 19(2); 291-93

24.. Martino P, Micozzi A, Venditti M: Rev Infect Dis, 1990; 12(2); 250-57

25.. Davis M, Gratten M, Ree GH: PNG Med J, 1982; 25(1); 7-11

26.. Lofgren RP, Nelson AE, Crossley KB: Am Heart J, 1981; 101(4); 502

27.. Bhattarai M, Papireddy M, Kulkarni S: J Hosp Med, 2016; 11(Suppl 1) http://www.shmabstracts.com/abstract/a-rare-case-of-complicated-achromobacter-xylosoxidans-endocarditis-and-its-successful-management

28.. lson DA, Hoeprich PD: West J Med, 1982; 136(2); 153-57


19 May 2022 : Case report  Serbia

Bilateral Emphysematous Pyelonephritis Associated with COVID Pneumonia: A Case Report

Am J Case Rep In Press; DOI: 10.12659/AJCR.936370  

17 May 2022 : Case report  USA

High-Frequency Oscillatory Ventilation for Refractory Hypoxemia in Severe COVID-19 Pneumonia: A Small Case ...

Am J Case Rep In Press; DOI: 10.12659/AJCR.936651  

13 May 2022 : Case report  Japan

A case of exacerbation of haloperidol-induced rhabdomyolysis following the onset of COVID-19

Am J Case Rep In Press; DOI: 10.12659/AJCR.936589  

13 May 2022 : Case report  USA

Acute Disseminated Encephalomyelitis After SARS-CoV-2 Vaccination

Am J Case Rep In Press; DOI: 10.12659/AJCR.936574  

In Press

23 May 2022 : Case report  Switzerland

Pharmacological and Behavioral Strategies to Improve Vision in Acquired Pendular Nystagmus

Am J Case Rep In Press; DOI: 10.12659/AJCR.935148  

23 May 2022 : Case report  USA

A Case of Methicillin-Sensitive Staphylococcus aureus (MSSA) Prostate Abscess, Osteomyelitis, and Myositis ...

Am J Case Rep In Press; DOI: 10.12659/AJCR.936704  

23 May 2022 : Case report  USA

Adalimumab Mitigates Lumbar Radiculopathy in a Case of Ankylosing Spondylitis

Am J Case Rep In Press; DOI: 10.12659/AJCR.936600  

20 May 2022 : Case report  Canada

Diagnostic Puzzle of Acute Ischemic Stroke Mimics – Seizure Versus Post-Stroke Recrudescence: A Case Report

Am J Case Rep In Press; DOI: 10.12659/AJCR.936826  

Most Viewed Current Articles

23 Feb 2022 : Case report  USA

Penile Necrosis Associated with Local Intravenous Injection of Cocaine

DOI :10.12659/AJCR.935250

Am J Case Rep 2022; 23:e935250

17 Feb 2022 : Case report  Oman

Myocarditis, Pulmonary Hemorrhage, and Extensive Myositis with Rhabdomyolysis 12 Days After First Dose of P...

DOI :10.12659/AJCR.934399

Am J Case Rep 2022; 23:e934399

06 Dec 2021 : Case report  Brazil

Lipedema Can Be Treated Non-Surgically: A Report of 5 Cases

DOI :10.12659/AJCR.934406

Am J Case Rep 2021; 22:e934406

19 Feb 2022 : Case report  USA

A Rare Case of Coronavirus Disease 2019 Vaccine-Associated Cerebral Venous Sinus Thrombosis Treated with Me...

DOI :10.12659/AJCR.935355

Am J Case Rep 2022; 23:e935355

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

American Journal of Case Reports eISSN: 1941-5923
American Journal of Case Reports eISSN: 1941-5923